Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM · Real-Time Price · USD
3.180
+0.720 (29.27%)
At close: Dec 20, 2024, 4:00 PM
2.300
-0.880 (-27.67%)
After-hours: Dec 20, 2024, 7:59 PM EST
Psyence Biomedical Market Cap
Psyence Biomedical has a market cap or net worth of $3.17 million as of December 20, 2024. Its market cap has decreased by -95.88% in one year.
Market Cap
3.17M
Enterprise Value
12.88M
1-Year Change
-95.88%
Ranking
Category
Stock Price
$3.18
Market Cap Chart
Since December 10, 2021, Psyence Biomedical's market cap has decreased from $323.48M to $3.17M, a decrease of -99.02%. That is a compound annual growth rate of -78.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 3.17M | -96.10% |
| Dec 29, 2023 | 81.20M | -75.83% |
| Dec 30, 2022 | 335.90M | 3.73% |
| Dec 31, 2021 | 323.81M | 0.10% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| China Pharma Holdings | 3.35M |
| Pasithea Therapeutics | 3.33M |
| Enveric Biosciences | 3.23M |
| GlucoTrack | 3.18M |
| Theriva Biologics | 3.17M |
| Azitra | 3.16M |
| NLS Pharmaceutics AG | 3.16M |
| InMed Pharmaceuticals | 3.16M |